Lumenis Executive and Leadership Team

Brad Oliver, the President & General Manager (Americas) at Lumenis, directs all commercial activities and market expansion efforts across the North and South American regions. Oliver oversees the sales and marketing teams responsible for promoting TriLift and other energy-based aesthetic solutions to medical practitioners. By managing regional distribution channels, the President & General Manager (Americas) ensures consistent product availability and high-quality customer support. This leadership role involves coordinating with global headquarters to adapt product messaging for specific regional market needs. Brad Oliver also monitors competitive dynamics to capture greater market share in the skin and eye care segments. Through the execution of targeted growth strategies, the President & General Manager (Americas) drives revenue performance and strengthens brand presence throughout the Americas. This operational focus supports the company's mission to provide advanced medical technologies to a broad clinical audience. Ultimately, Oliver maintains strong relationships with key medical stakeholders to ensure long-term regional success.

Masako Uchida, the President at Lumenis, defines the overarching corporate strategy and long-term vision for the global medical technology organization. Uchida oversees the alignment of manufacturing, research, and commercial departments to ensure consistent delivery of energy-based skin and eye care solutions. By managing the executive leadership team, the President fosters a culture of clinical innovation and operational excellence. This leadership role involves engaging with the board of directors to secure resources for future product development and international market expansion. Masako Uchida also directs the company's response to evolving regulatory requirements in the medical device industry. Through the implementation of high-level strategic initiatives, the President drives sustainable growth and maintains the company's reputation for quality. This focus on organizational health ensures that all departments contribute effectively to the core mission of improving patient outcomes. Ultimately, Uchida guides the company through complex market landscapes to achieve sustained global leadership.

Tahel Blum, the Chief Information Officer at Lumenis, architects the digital infrastructure supporting global manufacturing and distribution operations. Blum manages the enterprise resource planning systems that track the production of OptiPlus and Digital Duet devices. By overseeing cybersecurity protocols and data integrity, the Chief Information Officer protects sensitive clinical information across all regional networks. This leadership role involves aligning information technology strategies with the company's long-term growth objectives in the medical sector. Tahel Blum also drives the digital transformation of internal workflows to increase operational efficiency and reduce manufacturing downtime. Through the implementation of scalable cloud solutions, the Chief Information Officer enables seamless communication between international offices and production facilities. This technical oversight ensures that data-driven insights inform strategic decision-making at the executive level. Ultimately, Blum secures the digital foundation necessary for the continued expansion of the company's energy-based technology portfolio.

May Kleinman, the Director, Technologies at Lumenis, manages the research and development pipeline for energy-based medical devices. Kleinman directs the engineering teams responsible for the Stellar M22 and OptiLight platforms, ensuring all hardware meets rigorous clinical standards. By overseeing the integration of advanced light-based energy systems, the Director, Technologies optimizes product performance for dermatological and ophthalmic applications. This leadership role involves constant collaboration with clinical researchers to refine treatment efficacy across diverse patient demographics. May Kleinman also monitors emerging technological trends to maintain a competitive edge in the global medical device market. Through precise technical oversight, the Director, Technologies accelerates the commercialization of new energy-based solutions. This focus on innovation supports the broader mission of providing high-quality care tools to medical professionals worldwide. Ultimately, Kleinman ensures that every technological advancement aligns with the core manufacturing objectives of the organization.